
This study aims to determine tumour control rates for treating growing vestibular schwannoma (VS) with CyberKnife stereotactic radiosurgery (CK SRS). One hundred twenty-seven patients who received CK SRS for radiographically documented growing VS were reviewed. The tumour control rate was 94.5% for treating VS with CK SRS. In addition, hearing outcomes were categorized using the American Academy of Otolaryngology‐Head and Neck Surgery (AAO‐HNS) classification system. Based on the study findings, CK SRS is an effective treatment for the control of VS Hearing preservation by class was achieved in a third of patients. Finally, FCD was found to be protective against hearing loss.
Like
Save
Share